AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications
26-30 ottobre Philadelphia, Pennsylvania AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications
IMI K4DD Conference 2017. Binding kinetics: time is of the essence
16-18 ottobre Berlin, Germany IMI K4DD Conference 2017. Binding kinetics: time is of the essence
Cancer Bio-Immunotherapy – XV NIBIT meeting
3-7 ottobre Siena, Italy Cancer Bio-Immunotherapy – XV NIBIT meeting
XXXV Conferenza Nazionale di citometria
3-6 ottobre Paestum, Italy XXXV Conferenza Nazionale di citometria
8th World ADC Congress
20-22 settembre San Diego, CA 8th World ADC Congress Abstract: Thienoindoles, a novel class of potent toxins for antibody drug conjugates
40 Congress of the European Society of Medical Oncology
8-12 settembre Madrid, Spain 40 Congress of the European Society of Medical Oncology
EACR AACR SIC:The challenges of optimising immuno and targeted therapies – from cancer biology to clinic
24-27 giugno Firenze, Italia EACR AACR SIC:The challenges of optimising immuno and targeted therapies – from cancer biology to clinic Abstract: 318 – NMS-P088 is a small molecule potent CSF1R kinase inhibitor with macrophages immunomodulatory activity
18th Annual Drug Discovery Summit
12-13 giugno Berlino, Germany 18th Annual Drug Discovery Summit
VII Congresso nazionale organizzato da ISMRM Italian Chapter
8-9 giugno Gaeta, Italia VII Congresso nazionale organizzato da ISMRM Italian Chapter
AACR 2017
1-5 aprile Washington, USA AACR 2017 Abstract 5163 – Characterization of NMS-E194, a selective and potent PERK inhibitor with efficacy in the KMS-11 multiple myeloma Abstract 2082 –NMS-E668, a potent and selective RET kinase inhibitor characterized by specificity towards VEGFR2 and high antitumor efficacy against RET-driven models